Despite recent share price weakness, MBM Resources Berhad's robust Return on Equity and consistent earnings growth suggest the automotive group may be undervalued by the market.
A House hearing exposed disturbing text messages in which a Customs and Border Protection agent boasted about shooting a Chicago woman, fueling scrutiny of federal immigration enforcement tactics.
A new analysis from hiring platform Indeed places truck driving among the nation's strongest job opportunities, with top earners making up to $160,000 annually without a college degree, signaling a shift in the high-wage career landscape.
Figma stock faced a steep sell-off Tuesday after a major price target cut, highlighting broader investor pessimism towards software stocks amid a shifting tech landscape.
With Super Bowl LX approaching, NBCUniversal confirms unprecedented advertising rates, averaging $8 million per 30-second slot and reaching over $10 million for premium placements. The surge underscores the enduring power of live sports broadcasting in the streaming era.
Soleno Therapeutics reports robust preliminary Q4 2025 revenue of $90-$92 million from its rare-disease drug VYKAT XR, marking a potential inflection point. The company prepares to unveil full financials and present at key investor conferences, with the drug's early commercial success now central to its growth narrative.
Digital remittance firm Remitly Global reports its first full year of positive earnings per share, coupled with a nearly one-third surge in active customers. The turnaround highlights the company's growing operational strength amid a competitive fintech landscape.
Nintendo's latest earnings reveal record-breaking Switch sales and a robust Switch 2 launch, achieved despite significant tariff and memory chip cost pressures. While profits surged, the company's unchanged full-year guidance and margin resilience are now the focal points for investors.
Chipotle Mexican Grill's Q4 earnings reveal a troubling decline in comparable sales and tepid 2026 outlook, casting doubt on its premium market valuation as consumer visits drop.
Prominent longevity physician and author Dr. Peter Attia has resigned from his role at nutrition bar maker David Protein following the release of documents linking him to Jeffrey Epstein. The controversy now casts a shadow over Biograph, the medical testing startup he co-founded, which has removed references to him and declined to comment.
As LVMH navigates a shifting luxury landscape marked by softer demand in China, the group is placing a strategic bet on a renewed Dior to drive its fashion and leather goods division forward. This management and creative reset comes at a pivotal moment for the world's largest luxury conglomerate.
Textron's latest quarterly results and 2026 outlook, coupled with a completed $2.44 billion share repurchase and a key board appointment, suggest the industrial conglomerate is methodically recalibrating its growth and capital return priorities amidst a shifting defense and aerospace landscape.
Amcor reports Q2 adjusted EPS growth of 7%, driven by accelerating cost synergies from its transformative Berry acquisition. The packaging giant reaffirms its full-year outlook, citing strong execution and a clear path to deliver at least $260 million in synergies for fiscal 2026.
Shares of the Danish pharmaceutical giant tumbled over 14% as management's forecast of a sales and profit decline in 2026 shifted investor focus from blockbuster results to looming pricing battles and competitive threats in the crucial U.S. market.
Stockholders of Golub Capital BDC and affiliated funds have re-elected key directors and ratified Ernst & Young as auditor for the 2026 fiscal year, following a series of virtual annual meetings that underscored the firm's governance continuity amid a shifting private credit landscape.
California wildlife officials have granted final approval for a ground-based operation to remove invasive mule deer from Catalina Island, a significant revision from earlier, widely criticized proposals involving helicopter sharpshooters.
While Novo Nordisk and Eli Lilly dominate the booming obesity drug market, clinical-stage biotech Viking Therapeutics is emerging as a speculative but potentially transformative investment for those willing to embrace risk.
Despite a steady rise in earnings per share, Genting Plantations Berhad (KLSE:GENP) has seen its share price plummet 46% over the past five years, leaving long-term shareholders questioning their holdings. We delve into the disconnect between performance and market sentiment.
Shares of Rocket Companies surged over 8% Tuesday after CEO Varun Krishna signaled the firm's mortgage loan production hit a four-year high, sparking investor optimism for a housing demand rebound even as major indices declined.
CNN anchor Dana Bash issued a stark warning after former President Donald Trump advocated for a federal takeover of election administration, a move experts and critics say would upend the decentralized system enshrined in the U.S. Constitution and represents a continued assault on electoral integrity.
